We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn to distinguish between dysplastic nevi (atypical moles) and melanoma, the deadliest skin cancer. Understand symptoms, causes, diagnosis, treatment, and prevention strategies.

Understanding Dysplastic Nevi and Melanoma: A Guide for Indian Readers Skin health is a crucial aspect of overall well-being, and understanding the various moles and lesions on our skin is vital. In India, with its diverse population and varying sun exposure levels, it's important to be aware of conditions like dysplastic nevi (atypical moles) and melanoma, the deadliest form of skin cancer. While they can look similar, knowing the differences can be life-saving. This guide aims to clarify these conditions, their causes, symptoms, diagnosis, treatment, and prevention, tailored for an Indian audience. What are Dysplastic Nevi (Atypical Moles)? Dysplastic nevi, also known as Clark's nevi, are moles that look different from common moles. They are often larger and have irregular shapes, borders, and colours. While most common moles are harmless, dysplastic nevi have a higher chance of developing into melanoma, especially if you have many of them. Dysplastic nevi are graded based on their appearance under a microscope after a biopsy: Mild atypia: Slight abnormalities in cell structure. Moderate atypia: More noticeable abnormalities, larger size, and more irregular borders and colour. Severe atypia: Significant abnormalities, often indistinguishable from early melanoma. These require close monitoring and often surgical removal. What is Melanoma? Melanoma is a serious form of skin cancer that develops from melanocytes, the cells that produce melanin (the pigment that gives skin its colour). It is the most dangerous type of skin cancer because it has a higher likelihood of spreading to other parts of the body if not detected and treated early. While melanoma can occur anywhere on the body, it often develops in areas that have been exposed to the sun. Similarities and Differences: Spotting the Signs The confusion between dysplastic nevi and melanoma often arises because some severe dysplastic nevi can look very similar to melanoma. A biopsy is often the only definitive way to tell them apart. However, there are some general characteristics to look out for, often summarised by the ABCDE rule for melanoma: A - Asymmetry: One half of the mole does not match the other half. B - Border: The edges are irregular, ragged, notched, or blurred. C - Color: The colour is not the same all over and may include shades of brown or black, sometimes with patches of pink, red, white, or blue. D - Diameter: Melanomas are typically larger than 6 millimetres (about the size of a pencil eraser), although they can be smaller. E - Evolving: The mole is changing in size, shape, colour, or elevation, or is developing new symptoms like itching, tenderness, or bleeding. Compared to common moles, dysplastic nevi may have smoother, scaly, or rough patches, and irregular or faded borders. A new mole or a change in an existing mole is always a cause for concern. Causes and Risk Factors The exact causes of dysplastic nevi and melanoma are not always known, but several risk factors are associated with their development: Causes and Risk Factors for Dysplastic Nevi: Genetics: A family history of dysplastic nevi or melanoma. Sun Exposure: Excessive exposure to ultraviolet (UV) radiation from the sun, especially during childhood and adolescence. Skin Type: Fair skin that burns easily, freckles, and light-coloured hair and eyes. Dysplastic Nevus Syndrome: Having a large number of dysplastic nevi (often more than 50). Personal History: Previous diagnosis of melanoma or other skin cancers. Causes and Risk Factors for Melanoma: UV Radiation Exposure: The primary cause is exposure to UV radiation from sunlight or artificial sources like tanning beds. Genetics: A family history of melanoma significantly increases risk. Skin Type: Individuals with fair skin, red or blonde hair, and blue or green eyes are more susceptible. Numerous Moles: Having many moles, especially if some are atypical (dysplastic). The odds of developing melanoma are about 10 times higher for someone with five dysplastic nevi than for someone with none. Weakened Immune System: Conditions or medications that suppress the immune system. Age: Risk increases with age, though it is also a common cancer in young adults. Do Dysplastic Nevi Turn into Melanoma? While not all dysplastic nevi will turn into melanoma, severe dysplastic nevi have a higher potential to do so. The risk increases with the number of atypical moles present. It's estimated that about 30% of dysplastic nevi associated with specific gene mutations (BRAF or NRAS) are at risk of cancerous transformation. Although the lifetime risk of melanoma in India is generally lower than in Western countries (less than 1%), it can increase significantly (to over 10%) in individuals with atypical nevi. Diagnosis: How Doctors Identify These Conditions Diagnosing dysplastic nevi and melanoma typically involves: Visual Examination: A dermatologist will examine your skin and moles, looking for the ABCDE signs and other irregularities. Dermoscopy: A special magnifying tool that allows doctors to see structures within the mole not visible to the naked eye. Biopsy: This is the most definitive diagnostic tool. A small sample of the mole is removed and sent to a laboratory for microscopic examination by a pathologist. This confirms whether the mole is benign, dysplastic, or cancerous (melanoma). The biopsy also helps grade the severity of atypia in dysplastic nevi. Treatment Options Treatment depends on the diagnosis: Dysplastic Nevi: If a biopsy shows mild or moderate atypia, and the mole is not suspicious, it may only require regular monitoring. However, moderate to severe dysplastic nevi, or those that look concerning, are usually surgically removed to prevent
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026